CPSF4 and colorectal carcinoma: The results obtained with respect to the invasiveness and cytokine secretion prompted us to hypothesize that the anti-inflammatory properties observed previously with NAR and LYC in other disease models could be extended to cancer biology and may be of great value in the context of CRC therapy.